These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17043020)

  • 1. Concomitant aberrant overexpression of RUNX1 and NCAM in regenerating bone marrow of myeloid leukemia of Down's syndrome.
    Langebrake C; Klusmann JH; Wortmann K; Kolar M; Puhlmann U; Reinhardt D
    Haematologica; 2006 Nov; 91(11):1473-80. PubMed ID: 17043020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
    Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
    Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis.
    Gadgeel M; AlQanber B; Buck S; Taub JW; Ravindranath Y; Savaşan S
    Ann Hematol; 2021 Jul; 100(7):1695-1700. PubMed ID: 33890142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down's syndrome and leukemia].
    Bermúdez Cortés M; Verdeguer Miralles A; Jovaní Casano C; Cañete Nieto A; Fernández JM; Ferris Tortajada J; Castel Sánchez V
    An Esp Pediatr; 1998 Jun; 48(6):593-8. PubMed ID: 9662842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
    Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
    BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic progenitor cell deficiency in fetuses and children affected by Down's syndrome.
    Holmes DK; Bates N; Murray M; Ladusans EJ; Morabito A; Bolton-Maggs PH; Johnston TA; Walkenshaw S; Wynn RF; Bellantuono I
    Exp Hematol; 2006 Dec; 34(12):1611-5. PubMed ID: 17157155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
    Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
    Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of cell adhesion molecules in acute leukemia cell].
    Ju X; Peng M; Xu X; Lu S; Li Y; Ying K; Xie Y; Mao Y; Xia F
    Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):581-4. PubMed ID: 12482342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA1 mutations in acute leukemia in children with Down syndrome.
    Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
    Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
    Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.